Is Care Bare Rx Legit? What Our Registry Shows (2026)

Is Care Bare Rx a real, safe GLP-1 telehealth company? Verified pricing history, refund policy, states served, four named compounding pharmacies, and a named prescribing medical group with individually credentialed physicians, sourced from RangeYourself’s dated registry. No public Trustpilot or BBB listing was found as of our check.

By RangeYourselfLast verified July 25, 2026

Yes, Care Bare Rx is a real, operating GLP-1 telehealth company. RangeYourself has independently verified its pricing directly against its own site since June 30, 2026, most recently on July 25, 2026, and its refund/cancellation terms and states served are published on its own site, the evidence for that verdict is the dated verification trail below, not a claim we're asking you to take on faith.

How long we’ve tracked Care Bare Rx

RangeYourself first recorded a verified price for Care Bare Rx on June 30, 2026, sourced directly from Care Bare Rx’s own site. Since then we’ve logged 1 dated price check on this program, most recently July 25, 2026. That dated trail , not a one-time snapshot, is what a legitimacy check on a telehealth program should rest on.

Pricing verification history

June 30, 2026: $199/mobaseline snapshot, price-history tracking began 2026-07-14; seeded from the current verified price only (no prior prices invented)

Refund and cancellation policy

Care Bare Rx’s own stated policy: Cancel anytime; no refund on dispensed compounds

Price and terms on file

Price: $199/mo (flat monthly rate)

Membership fee: No separate membership fee

Price last verified: July 25, 2026

States served

Care Bare Rx ships to all US states except Louisiana, per its own site (verified July 25, 2026).

Verified programs that cost less than Care Bare Rx

Care Bare Rx’s own verified figure is $199/mo (flat monthly rate). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 14, 2026.

1.Embody
$69/mo (limited-time promo), verified September 5, 2026
See pricing →
2.Strut Health
$99/mo (sublingual/oral starting price), verified August 21, 2026
See pricing →
3.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →
4.HealthRX
$99/mo (12-month plan rate), verified August 21, 2026
See pricing →
5.bmiMD
$119/mo (12-month plan rate), verified September 3, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

See Care Bare Rx pricing → Read the full Care Bare Rx review →

Frequently asked questions

Is Care Bare Rx a real company?

Yes. RangeYourself has independently verified Care Bare Rx's pricing directly against its own site (www.carebarerx.com), first checked June 30, 2026 and most recently re-verified July 25, 2026, across 1 dated price check on file, and its refund policy and states served are published on its own site.

Is Care Bare Rx FDA-approved?

No. Care Bare Rx prescribes compounded semaglutide and/or tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved as a finished product. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

Does Care Bare Rx offer refunds or a guarantee?

Care Bare Rx's own stated policy: Cancel anytime; no refund on dispensed compounds This is the program's own policy, not a promise from RangeYourself, confirm current terms directly with Care Bare Rx before enrolling.

What do independent reviews show for Care Bare Rx?

We found no public Trustpilot or BBB listing for Care Bare Rx as of our check, absence of a listing is not evidence of a problem, but it also means there is no independent third-party record to cite.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. This legitimacy check reflects registry data verified through July 25, 2026 and may change.